One Site. One Team. Your Project.
Icosagen CRDMO

Flexible, research-driven collaboration with dependable delivery and a strong focus on the scientific needs of the project.

Eugeen Vanmechelen CSO and Founder, ADx NeuroSciences

Icosagen developed a robust expression and purification approach for a technically complex target after earlier providers had struggled, delivering high-purity, biologically active protein.

Emil Ruvinov, PhD Department Manager, Protein-Technology-Discovery Biotherapeutics, Ferring Therapeutics

Advesya highlights a smooth and professional ADC collaboration, with high-quality antibody production delivered within the agreed timelines and budget.

Stephane Lameynardie Head of PMO, Director Technical Operations & Alliance, Advesya

Strong CRO support for recombinant protein production and purification.

Ilgar Mamedov Head of Lead generation team, Egle Therapeutics

Montis Biosciences highlights professionalism, client-focused problem solving and strong scientific quality.

Ward Celus Scientific Operations Manager, Montis Biosciences

Reliable biotechnology support with the flexibility to adapt to custom project requirements.

Paolo Michieli Founder and CEO, Klasther Biopharma

Flexible CRO support across protein- and antibody-based projects.

Jaime Guillén Senior Research Scientist, ImCheck Therapeutics

Across more than ten projects, IOME Bio highlights consistent protein quality, reliability, fast turnaround, transparent communication and professional project management.

Japar Shamshiev CSO, IOME Bio

Ridgeline Discovery highlights responsive communication, flexibility, transparency, collaborative working and high quality.

Ridgeline Discovery Client organisation

Strong scientific expertise supporting demanding biotechnology projects.

Jean-Marc Herbert Founder and CEO, Abcely

Lys Therapeutics credits Icosagen's biochemical and molecular biology expertise, scientific support and proactive problem solving with helping accelerate its research programmes.

Manuel Blanc Co-founder and CEO of Lys Therapeutics

Orionis Biosciences values the team's proactive approach and flexibility, particularly for proteins beyond conventional antibody formats.

Orionis Biosciences Client organisation

Biomunex highlights personal attention and high-quality service.

Biomunex Pharmaceuticals Client organisation

Orion Pharma highlights easy communication and efficient service ordering.

Orion Pharma Client organisation

The University of Helsinki highlights fast and professional service.

University of Helsinki Academic research partner

Lys Therapeutics values scientific advice, flexibility and access to additional analytics when unexpected protein-production results require further investigation.

Lys Therapeutics Client organisation

Olink highlights a high success rate and straightforward communication.

Olink Client organisation

A long-term client highlights Icosagen's broad antibody-expression toolbox, robust QMCF platform, dependable delivery, high-quality reporting, transparent pricing and supportive problem solving.